Alex Rice leads global partnerships at ModelOp, connecting enterprise AI governance with the world’s top tech platforms.
Over the past year co-branding our go to market solution with SolluCIO Partners, one reality has become clear: leaders in healthcare, financial services, and biotech aren't struggling to find AI use cases—they are drowning in them. In our conversations with enterprise IT executives, CMIOs, chief risk and model risk officers, and heads of R&D informatics, I hear the same story. Health systems are managing an influx of homegrown predictive algorithms, vendor-embedded tools inside Epic, and emerging agentic workflows. Banks and insurers are extending decades-old model risk management programs built for credit and capital models to generative assistants, fraud detection, and underwriting copilots. Biotech and life sciences organizations are pushing AI into discovery, clinical trial operations, pharmacovigilance, and GxP-regulated manufacturing, where every model touching a regulated decision must be validated, versioned, and defensible. These are high-impact environments: a single unmonitored model can affect patient safety, capital adequacy, or product quality. AI governance is top-of-mind in 2026, but it's a complex landscape often divided into a collection of isolated point-solution features—shadow AI detection or observability or traditional data governance—that don't talk to each other and fail to scale across an enterprise tech stack.
“In regulated industries, the hard part was never building the model—it's proving, months or years later, that the model still does what you said it would do,” said Paul Anderson, Vice President of Advisory Services at SolluCIO Partners. “We work with CIOs and risk leaders across health systems, banks, insurers, and life sciences companies who have strong policies on paper and no way to enforce them at runtime. Pairing our clinical, financial, and GxP validation playbooks with ModelOp's control plane means governance stops being an annual audit exercise and becomes something that runs every time a model is trained, deployed, or called.”
One Size Does Not Fit All in AI Governance
When the SolluCIO team sat down with us to architect this joint offering, we focused heavily on the fact that different AI archetypes—and different regulatory regimes—require fundamentally different governance controls:
- Homegrown Predictive Models: Demand quantitative risk scoring, independent validation and challenger testing, bias and drift audits, and alignment with FDA Good Machine Learning Practice (GMLP) for clinical models and Federal Reserve SR 11-7 / OCC 2011-12 model risk management standards for credit, fraud, and underwriting models—documentation and monitoring evidence rather than real-time runtime blocking.
- Agentic Systems & Generative Tools: Require inline runtime guardrails, prompt and output logging, token and cost tracking, and automated human-in-the-loop (HITL) gates to safeguard Protected Health Information (PHI), material non-public information and customer financial data, and proprietary compound, assay, and trial data. In high-impact settings—clinical decision support, trading and claims workflows, lab and manufacturing operations—these controls have to be enforced at call time, not reviewed after the fact.
- Vendor & Third-Party Model Integrations: Depend on specialized Third-Party Risk Management (TPRM), contractual controls over model change, retraining notification, and data use, and strict evaluation against HIPAA/HITRUST for EHR-embedded tools, GLBA, NYDFS, and EU AI Act obligations for financial services, and 21 CFR Part 11, GxP, and computer software assurance expectations for life sciences platforms.
- Foundation Models & Research Pipelines: Need provenance tracking across training and fine-tuning data, reproducibility of results used in regulatory submissions, export and IP controls, and clear separation between exploratory research use and production or patient-facing use.
Bridging Software Control Planes with Domain Expertise
With my experience delivering this platform, I know that software alone cannot solve an organizational challenge, nor can consulting frameworks sitting unused in a slide deck. That is the exact gap our partnership closes. ModelOp provides the automated central control plane—enterprise AI inventory, policy-driven workflows, lifecycle approvals, monitoring, and audit-ready evidence across ML, generative, agentic, internal, and third-party systems. SolluCIO brings the deep data architecture, clinical and model validation expertise, and regulatory playbooks needed to direct it: HIPAA and HITRUST controls for health systems, SR 11-7-aligned model risk management for banks and insurers, and GxP and 21 CFR Part 11 validation practices for biotech and pharma. By embedding SolluCIO's frameworks directly inside ModelOp, together we turn passive policies into continuous, automated execution—so a model risk tier, a bias test, or a HITL requirement becomes a gate in the delivery pipeline rather than a paragraph in a policy document.
Working hands-on with SolluCIO's leadership and data scientists has proven that combining enterprise-grade technology orchestration with battle-tested data architecture gives high-impact organizations a repeatable path from operational inertia to industrialized AI model management: every model inventoried, tiered by risk, monitored in production, and retired on evidence rather than instinct. Together, we are helping health systems, financial institutions, and life sciences companies scale innovation rapidly without compromising safety, compliance, capital discipline, or patient and customer trust.
About SolluCIO Partners
Founded in 2014 and headquartered in Seattle, Washington, SolluCIO Partners delivers “Solutions for the CIO” across healthcare, financial services, life sciences, retail, energy, and government. Through its Advisory, Data Services, Cybersecurity, Recruiting, and Ventures divisions, SolluCIO provides fractional and interim CIO leadership, AI and data governance advisory, data management and Microsoft Fabric engineering, cybersecurity and SOC 2 readiness, vCISO services, and application development. Its healthcare and AI governance practices pair enterprise architecture and data management depth with hands-on regulatory experience in HIPAA, HITRUST, GxP, and model risk management. Learn more at solluciopartners.com.
About ModelOp
ModelOp is the award-winning AI Delivery Platform for enterprise AI leaders: an Enterprise AI Command Center for CIOs, CTOs, and AI leaders used by the most complex and regulated institutions in the world, including major banks, insurers, regulatory bodies, healthcare organizations, government, defense, manufacturing, energy, and global CPG companies. It provides a system of record that powers workflows and generates operational intelligence in one operating layer to industrialize the delivery of all AI: ML, GenAI, Agentic AI and vendor AI.
ModelOp is interoperable and sits above existing AI tech stacks—MLOps, GRC, ITSM, security, data management—connecting and extending those investments. It enables the world’s enterprises to accelerate AI from idea to production and deliver AI rapidly, safely, and profitably.
Gartner, Forrester, and IDC recognized ModelOp for its end-to-end AI lifecycle management and AI governance capabilities. It also has been recognized with multiple awards, including the “Best AI Governance Software Award” from Netty Awards; Business Intelligence Group’s “Artificial Intelligence Excellence Award”; and the Diamond Award for “Responsible AI Platform” in the Pinnacle Awards for Artificial Intelligence.
